Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses the longstanding treatment options used in addition to chemotherapy, including antiadrogens and CYP inhibitors.…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses Androgen Deprivation Therapy. Androgen Deprivation Therapy is the gold standard for men with metastatic…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses her experience with men who have been treated aggressively for low grade, low volume…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses new research led by the Eastern Cooperative Oncology group looking at a RCT of…
The American Association of Clinical Endocrinologists 2011 Conference takes place on April 13-17 and The Doctor’s Channel will be providing daily highlights coverage. Check back daily for highlights…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses how radical prostatectomy can provide a definitive cure in many cases of prostate cancer.…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses how prostate cancer requires an integrated multidisciplinary approach. Related ReadingEnhancing prostate cancer care through…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses the diagnosis of prostate cancer and what a man needs to know. The three…
NEW YORK (Reuters Health) – A low-dose regimen of peginterferon, without ribavirin, produces a sustained virologic response in up to 40% of patients with chronic hepatitis C and…
